Form 4 for BIIB Biogen
Accepted 2022-07-06 00:00:00 ET · period of report 2022-07-01 · accession 0001127602-22-019020 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-06 | 2022-07-01 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | F - Tax | $210.63 | -148 | 2,110 | -7% | -$31.2K |
| D | 2022-07-06 | 2022-07-01 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | +504 | 2,258 | +29% | $0 |
| D | 2022-07-06 | 2022-07-01 | BIIB | Izzar Rachid | Head of Alzheimer's Disease | M - OptEx | $0.00 | -504 | 504 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | F | D | 148 | $210.63 | 2,110 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-01 | M | A | 504 | $0.00 | 2,258 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2022-07-01 | M | D | 504 | $0.00 | 504 | D | $0.00 · — to 2024-07-01 | 504 Common Stock | (F1) This award was granted to the reporting person on July 1, 2020, and will vest in three equal installments on each anniversary of the grant date. |